Background: Lipid metabolism is vital to fetal development and cardiometabolic health and the final weeks of gestation are known to be a time of intense metabolic activity. New techniques such as lipidomics allow investigation of a complex lipidomic profile in infants. Objectives: This research aimed to (1) describe variations in lipidomic profile in late preterm and term infants and (2) compare variations to an adult lipidomic profile with known clinical implications. Methods: The Barwon Infant Study (n = 1,074) is a population-derived pre-birth cohort study. The lipidomic profile of cord blood was measured by liquid chromatography-mass spectrometry in 225 participants and the association between gestational age and lipidomic profile was investigated using multiple linear regression adjusting for birth weight, exposure to labour, and infant sex. Patterns of association with gestational age across the lipidomic profile were compared with associations between body mass index (BMI) and lipidomic profile observed among adults in the San Antonia Family Heart Study (n = 994). Results: Gestational age was independently associated with the abundances of 39% of lipid species. Variations in the lipidomic profile with increasing gestational age were comparable to some variations observed in association with increasing BMI among adults. Conclusion: There is a strong relationship between gestational age and the cord blood lipid profile at birth, providing further evidence for the importance of metabolic changes of late gestation. A number of the variations in the lipid profile with increasing gestational age are analogous to differences observed in the adult lipid profile with an increasing BMI.

Keywords:
Developmental origins of disease, Lipid metabolism, Gestational age, Neonate
1.
Ghaemi S, Najafi R, Kelishadi R: Cord blood lipoprotein profile in term, preterm, and late preterm newborns. J Res Med Sci 2014; 19: 1038–1040.
2.
Gunes T, Koklu E, Ozturk MA: Maternal and cord serum lipid profiles of preterm infants with respiratory distress syndrome. J Perinatol 2007; 27: 415–421.
3.
Weir JM, Wong G, Barlow CK, Greeve MA, Kowalczyk A, Almasy L, et al: Plasma lipid profiling in a large population-based cohort. J Lipid Res 2013; 54: 2898–2908.
4.
Meikle PJ, Wong G, Tsorotes D, Barlow CK, Weir JM, Christopher MJ, et al: Plasma lipidomic analysis of stable and unstable coronary artery disease. Arterioscler Thromb Vasc Biol 2011; 31: 2723–2732.
5.
Vuillermin P, Saffery R, Allen KJ, Carlin JB, Tang ML, Ranganathan S, et al: Cohort profile: the Barwon Infant Study. Int J Epidemiol 2015; 44: 1148–1160.
6.
Wong G, Barlow CK, Weir JM, Jowett JB, Magliano DJ, Zimmet P, et al: Inclusion of plasma lipid species improves classification of individuals at risk of type 2 diabetes. PLoS One 2013; 8:e76577.
7.
Benjamini Y, Hochberg Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 1995; 57: 289–300.
8.
Fisher RA: Frequency distribution of the values of the correlation coefficient in samples from an indefinitely large population. Biometrika 1915; 10: 507–521.
9.
De Livera AM, Bowne JB: Metabolomics: Statistical Analysis of Metabolomics Data. R package version 0.1.4. https://CRAN.R-project.org/package=metabolomics2014.
10.
Tohmaz U, Raid MR: Cord blood lipid profile in premature, near-term and term newborn infants. Iranian J Neonatol 2013; 4: 8–10.
11.
Tanner JM, Whitehouse RH: Revised standards for triceps and subscapular skinfolds in British children. Arc Dis Child 1975; 50: 142–145.
12.
Tikellis G, Ponsonby AL, Wells JC, Pezic A, Cochrane J, Dwyer T: Maternal and infant factors associated with neonatal adiposity: results from the Tasmanian Infant Health Survey (TIHS). Int J Obes 2012; 36: 496–504.
13.
Diaz-Castro J, Florido J, Kajarabille N, Prados S, de Paco C, Ocon O, et al: A new approach to oxidative stress and inflammatory signaling during labour in healthy mothers and neonates. Oxid Med Cell Longev 2015; 2015: 178536.
14.
Jung UJ, Choi MS: Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci2014; 15: 6184–6223.
15.
Casey CE, Neifert MR, Seacat JM, Neville MC: Nutrient intake by breast-fed infants during the first five days after birth. Am J Dis Child 1986; 140: 933–936.
16.
Noel-Weiss J, Courant G, Woodend AK: Physiological weight loss in the breastfed neonate: a systematic review. Open Med 2008; 2:e99–e110.
17.
Meikle PJ, Summers SA: Sphingolipids and phospholipids in insulin resistance and related metabolic disorders. Nat Rev Endocrinol 2017; 13: 79–91.
18.
Clandinin MT, Chappell JE, Heim T, Swyer PR, Chance GW: Fatty acid utilization in perinatal de novo synthesis of tissues. Early Hum Dev 1981; 5: 355–366.
19.
Lauritzen L, Brambilla P, Mazzocchi A, Harslof LB, Ciappolino V, Agostoni C: DHA effects in brain development and function. Nutrients 2016; 8:E6.
20.
Harvey N, Dhanwal D, Robinson S, Kim M, Inskip H, Godfrey K, et al: Does maternal long chain polyunsaturated fatty acid status in pregnancy influence the bone health of children? The Southampton Women’s Survey. Osteoporos Int 2012; 23: 2359–2367.
21.
Cheong JL, Doyle LW, Burnett AC, Lee KJ, Walsh JM, Potter CR, et al: Association between moderate and late preterm birth and neurodevelopment and social-emotional development at age 2 years. JAMA Pediatr 2017; 171:e164805.
22.
Meldrum SJ, D’Vaz N, Simmer K, Dunstan JA, Hird K, Prescott SL: Effects of high-dose fish oil supplementation during early infancy on neurodevelopment and language: a randomised controlled trial. Br J Nutr 2012; 108: 1443–1454.
23.
Byelashov OA, Sinclair AJ, Kaur G: Dietary sources, current intakes, and nutritional role of omega-3 docosapentaenoic acid. Lipid Technol 2015; 27: 79–82.
24.
Nestel PJ, Straznicky N, Mellett NA, Wong G, De Souza DP, Tull DL, et al: Specific plasma lipid classes and phospholipid fatty acids indicative of dairy food consumption associate with insulin sensitivity. Am J Clin Nutr 2014; 99: 46–53.
25.
Mamtani M, Kulkarni H, Wong G, Weir JM, Barlow CK, Dyer TD, et al: Lipidomic risk score independently and cost-effectively predicts risk of future type 2 diabetes: results from diverse cohorts. Lipids Health Dis 2016; 15: 67.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.